Pembrolizumab Plus Paclitaxel Extends Survival in Platinum-Resistant Ovarian Cancer
Phase 3 trial shows immunotherapy combination significantly improves progression-free and overall survival in recurrent ovarian cancer patients.
688 articles in this topic
Phase 3 trial shows immunotherapy combination significantly improves progression-free and overall survival in recurrent ovarian cancer patients.
New research reveals how tumors communicate with immune cells to avoid detection, potentially leading to better biomarkers and treatments.
Large UK study reveals metformin users have dramatically lower rates of dangerous DNMT3A mutations that lead to blood cancer.
New research shows how activating PKM2 enzyme enhances CD8 T cell function and improves anti-PD1 cancer therapy effectiveness.
Researchers identified why rare blood clots occur after certain COVID vaccines and developed a solution to prevent them in future vaccines.
New review shows AI dramatically improves cancer detection in radiology and pathology while providing explainable results for clinicians.
New research reveals why BET inhibitor cancer drugs work in labs but fail in patients, pointing to better treatment strategies.
New research explores yoga as complementary therapy for painful peripheral neuropathy affecting up to 70% of chemotherapy patients.
Comprehensive analysis reveals worldwide patterns of cancer in children and teens from 1990-2023, highlighting regional disparities.
Researchers developed rat and mouse models mimicking early and middle stages of oral submucous fibrosis using bleomycin injections.
Comprehensive review reveals how cancer cells manipulate immune recognition and promising therapeutic strategies to restore T cell immunity.
New research identifies HBO1 as a key driver of cancer cell transformation and resistance to CAR-T cell therapy in ovarian cancer.